Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adverse Effect and Immunogenicity of Vaccine”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)Study completedNCT01764126
What this trial is testing

Pneumococcal Protein Vaccine Safety and Immunogenicity Trial

Who this might be right for
Adverse Effects
International Centre for Diarrhoeal Disease Research, Bangladesh 280
Post-approval studies (Phase 4)UnknownNCT04801667
What this trial is testing

Evaluate the Impact, Safety, Tolerability and Immunogenicity of the Coronavac Vaccine in Kidney Transplant Recipients

Who this might be right for
SARS-CoV InfectionCoronavirus InfectionVaccine Adverse Reaction
Hospital do Rim e Hipertensão 3,371
Testing effectiveness (Phase 2)Study completedNCT01512706
What this trial is testing

A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants

Who this might be right for
The Study Focused on the Safety of Inactivated EV71 Vaccine (Human Diploid Cell) Against Hand, Foot and Mouth Disease in Chinese Children and Infants
Institute of Medical Biology, Chinese Academy of Medical Sciences 660
Testing effectiveness (Phase 2)Study completedNCT04530357
What this trial is testing

Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Large-scale testing (Phase 3)Study completedNCT05546502
What this trial is testing

Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

Who this might be right for
Vaccine ReactionVaccine Adverse Reaction
PT Bio Farma 1,050
Testing effectiveness (Phase 2)Study completedNCT04949490
What this trial is testing

A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects

Who this might be right for
COVID-19SARS-CoV-2 Infection
BioNTech SE 137
Testing effectiveness (Phase 2)UnknownNCT05409261
What this trial is testing

Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine

Who this might be right for
COVID-19Vaccine ReactionSARS CoV 2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Post-approval studies (Phase 4)Study completedNCT01896596
What this trial is testing

Hepatitis B Vaccination in Infants

Who this might be right for
Meningococcal DiseasePneumococcal DiseaseHaemophilus Influenzae Serotype b Disease+2 more
Public Health England 300
Not applicableUnknownNCT04832932
What this trial is testing

The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes

Who this might be right for
COVID-19 Vaccines
Mebo Research, Inc. 2,000
Large-scale testing (Phase 3)Study completedNCT03971370
What this trial is testing

Immunogenicity and Safety of A Lyophilized Purified Human Diploid Cell Rabies Vaccine .

Who this might be right for
Adverse Effect and Immunogenicity of Vaccine
Jiangsu Province Centers for Disease Control and Prevention 1,800
Early research (Phase 1)UnknownNCT03739229
What this trial is testing

Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine

Who this might be right for
Vaccine Adverse Reaction
Research Institute of Influenza, Russia 40
Testing effectiveness (Phase 2)UnknownNCT05409300
What this trial is testing

Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea

Who this might be right for
COVID-19Vaccine Adverse ReactionSars-CoV-2 Infection+1 more
ANRS, Emerging Infectious Diseases 200
Testing effectiveness (Phase 2)WithdrawnNCT00989274
What this trial is testing

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Who this might be right for
Influenza
Instituto Nacional de Salud Publica, Mexico
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078357
What this trial is testing

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Who this might be right for
Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse Reaction+3 more
University of Sao Paulo General Hospital 60
Large-scale testing (Phase 3)Study completedNCT06078423
What this trial is testing

A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)

Who this might be right for
Rabies Vaccine Adverse Reaction
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 1,880
Large-scale testing (Phase 3)UnknownNCT04852068
What this trial is testing

A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)

Who this might be right for
Rabies Vaccine Adverse ReactionSafety and Efficacy
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2,480
Large-scale testing (Phase 3)Study completedNCT04691908
What this trial is testing

Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 3,000
Not applicableUnknownNCT05258708
What this trial is testing

COVID-19 Vaccine Reactogenicity and Immunogenicity

Who this might be right for
COVID-19Vaccine Immune ResponseVaccine Adverse Reaction
Korea University Guro Hospital 179
Post-approval studies (Phase 4)Study completedNCT05898464
What this trial is testing

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Who this might be right for
Vaccination; InfectionVaccine Adverse Reaction
Seoul National University Hospital 71
Next Page